OncView™ Podcast: Connie Batlevi, MD, PhD on R/R Follicular Lymphoma Therapy Updates
Connie Batlevi, MD, PhD, detailed important updates in therapies for relapsed/refractory follicular lymphoma in this episode of CancerNetwork’s® podcast.
As part of the OncView video series, CancerNetwork® spoke with Connie Batlevi, MD, PhD, a medical oncologist at Memorial Sloan Kettering Cancer Center, about recent updates in therapies for relapsed or refractory follicular lymphoma. Batlevi discussed the current treatment options for this disease, as well as third-line therapies, tazemetostat (Tazverik), and sequencing changes.
In the video series, Batlevi discussed the following:
- Current Treatment Options and Considerations for Relapsed/Refractory Follicular Lymphoma
- Third-Line Therapies in R/R FL
- Use of Tazemetostat in R/R FL
- Sequencing Changes in R/R FL Therapies
To watch more videos in CancerNetwork’s® OncView™ series, visit cancernetwork.com/oncview.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
